検索結果

c atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819-835. 2 Cheung, C.M.G., Chen, Y., Holz, F.G. et al. Geographic atrophy...

s first successful clinical development of a TRPV1 antagonist for DED, completed in Japan. DED, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...

s first successful clinical development of a TRPV1 antagonist for DED, completed in Japan. DED, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...

announce today that it has been applied for manufacturing and marketing approval in Japan. DED, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...

administration trial demonstrated positive results confirming the safety of clinical use. DED, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...